Skip to content
Review Open access

Nanozymes in Tumor Microenvironment Modulation for Cancer Therapy

Sep 2026 · Biomaterials Research · Vol 30 · 0 citations · 216 references
Medicine

TL;DR

This review systematically summarizes recent advances in nanozyme-mediated regulation of the TME and aims to provide a theoretical basis and research perspectives for the further study, rational design, and translational application of nanozymes in cancer therapy.

Abstract

The tumor microenvironment (TME) plays a central regulatory role in malignant tumor progression and therapeutic resistance, and its complexity and dynamic heterogeneity markedly limit the efficacy of current treatment strategies. Therefore, the development of novel functional materials capable of effectively remodeling the TME and alleviating immunosuppression and therapeutic tolerance has become an important research direction in cancer therapy. In recent years, nanozymes, as a class of nanomaterials with enzyme-mimicking catalytic activity, have shown broad potential in TME intervention and the enhancement of cancer therapy owing to their excellent physicochemical stability, tunable structural properties, and multiple biomimetic enzyme-like activities. This review systematically summarizes recent advances in nanozyme-mediated regulation of the TME. First, the basic concepts, catalytic properties, and functional classifications of nanozymes are introduced. Subsequently, the mechanisms by which nanozymes remodel the TME and enhance cancer therapy are discussed from the key dimensions of the redox microenvironment, metabolic microenvironment, and immune microenvironment. Finally, the major challenges, barriers to clinical translation, and future development directions in this field are highlighted. This review aims to provide a theoretical basis and research perspectives for the further study, rational design, and translational application of nanozymes in cancer therapy.

Read PDF

Similar papers

Review Oct 2026

Multidimensional Regulation of Metal Ions in the Tumor Microenvironment and Innovative Strategies for Diagnosis and Therapy.

Metal ions serve as key regulators of the dynamic equilibrium within the tumor microenvironment (TME). In recent years, the TME has emerged as a central regulatory hub for tumor initiation, progression, and metastasis; its complexity has become both a frontier and a major challenge in oncology research. Current therapi...

Yan-Na Bi, Ya-Ting Zhao, Yan-Lei Ge et al. · 0 citations
Review Open access Oct 2026

Tumor Microenvironment-Responsive Smart Nanodrug Delivery Systems for Cancer Theranostics

Acidity, hypoxia, redox imbalance, and altered enzyme activity in the tumor microenvironment (TME) can be used to regulate nanocarrier structure and drug release. However, these conditions vary among tumors and across regions within individual tumors and overlap with certain normal physiological and inflammatory proces...

Xiu-Lin Wen, Yong-Xin Jiang, H. Yang et al. · 0 citations
Review Open access Sep 2026

Targeting the tumor microenvironment: a new strategy for natural products in breast cancer therapy

The development and drug resistance of breast cancer are closely associated with the heterogeneity of the tumor microenvironment (TME). Immunosuppressive cells, activated matrix components, abnormal vascular networks, and metabolic reprogramming within the TME collectively create a niche that promotes tumor survival. D...

Yan-Cai Liu, Yan-Ran Yang, Jiang-Long Wang et al. · 0 citations
Open access Nov 2026

An Organo–Inorganic Hybrid Nanomaterial to Disrupt Multicellular Communication within Tumor Microenvironment

The lack of clear identification or understanding of the key perpetrators activating the tumor microenvironment (TME) impedes development of TME-modulating therapeutic strategies that could overcome the challenges associated with tumor growth, metastasis, and therapy resistance. Here, we report the development of a h...

Prasanta Panja, S. K. Gulla, Yu-Shan Zhang et al. · 0 citations
Review Oct 2026

Nanocarrier-Based Drug Delivery Systems for Remodeling the Melanoma Tumor Microenvironment.

Melanoma remains a major therapeutic challenge in dermatologic oncology because of its aggressive nature and high mortality rate, with traditional therapeutic approaches exhibiting significant limitations in efficacy. Although nanodrug delivery systems (NDS) present a promising paradigm to overcome existing therapeutic...

Han-Qi Wang, Chen-Yu Sun, Han-Lin Wang et al. · 0 citations
Review Open access Nov 2026

Advances in the Research of Dual-Atom Nanozymes for Tumor Therapy

Dual-atom nanozymes (DAzymes) provide a new research strategy for regulating catalytic reaction pathways and redox homeostasis in tumor microenvironments (TMEs) by constructing adjacent metal active centers with specific coordination environments. Compared to traditional nanoparticle nanozymes and single-atom nanozymes...

Cong Lu, Wen-Xia Wang, Jie Chang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.